MARKET

ALDR

ALDR

Alder
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.88
-0.04
-0.21%
Delisted 09:30 11/08 EST
OPEN
18.95
PREV CLOSE
18.92
HIGH
19.12
LOW
18.83
VOLUME
29.12M
TURNOVER
--
52 WEEK HIGH
19.12
52 WEEK LOW
8.39
MARKET CAP
1.58B
P/E (TTM)
-4.2396
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALDR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ALDR News

  • 4 RNA Therapy Stocks For A Biotech Portfolio
  • Seeking Alpha - Article.11/07 19:20
  • Did Hedge Funds Drop The Ball On On Alder Biopharmaceuticals Inc (ALDR) ?
  • Insider Monkey.10/29 00:56
  • Healthcare And Biotechs Struggle, But Opportunity Ahead
  • Seeking Alpha - Article.10/23 06:24
  • Stocks That Hit 52-Week Highs On Monday
  • Benzinga.10/21 15:06

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About ALDR

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated for migraine prevention. Eptinezumab is a monoclonal antibody that inhibits calcitonin gene-related peptide (CGRP), a protein that is active in mediating the initiation of migraine. Alder is additionally evaluating ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), another protein that is active in mediating the initiation of migraine. Clazakizumab, Alder's third program, is a monoclonal antibody candidate that inhibits interleukin-6 and is licensed to Vitaeris, Inc.
More

Webull offers Alder Biopharmaceuticals Inc (ALDR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.